FDA.reportPublic FDA data

Trulance 3 MG Oral Tablet

RxCUI
1873765
RxNorm name
Trulance 3 MG Oral Tablet
Display name
Trulance 3 MG Oral Tablet
Full name
Trulance 3 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Trulance Immediate releasePLECANATIDESalix Pharmaceuticals Inc.fe2895bf-71a6-493a-b0ca-e06b2dfefc822024-04-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1873765

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fe2895bf-71a6-493a-b0ca-e06b2dfefc82Trulance 3 MG Oral Tablet [PSN] · plecanatide 3 MG Oral Tablet [Trulance] [SBD] · Trulance 3 MG Oral Tablet [SY]315These highlights do not include all the information needed to use TRULANCE safely and effectively. See full prescribing information for TRULANCE. TRULANCE ® (plecanatide) tablets, for oral use Initial U.S. Approval: 201720240404